In conjunction with its Second Annual Wellness Day, the Willoughby Golf Club is pleased to present a world-class geneticist as its featured luncheon speaker.
Rudy Tanzi, Ph.D., one of the foremost researchers into Alzheimer's disease and chair of the Cure Alzheimer's Fund Research Consortium, will speak about the latest developments in understanding the disease pathology and targeting interventions toward a cure.
Posted: Oct. 7, 2013
Our congratulations to Dr. Thomas C. Sϋdhof of Stanford University, a member of Cure Alzheimer’s Fund's Research Consortium, who joins Randy Scheckman of the University of California, Berkeley and James E. Rothman of Yale University in winning the Nobel Prize in Physiology or Medicine as announced today.
Posted: Mar. 28, 2013
Collaboration with the New York Stem Cell Foundation will involve using skin samples and brain imaging to identify causes and cures
Posted: Nov. 12, 2012
Consensus among Alzheimer’s researchers about the origins of the disease is growing. Most, including members of Cure Alzheimer’s Fund Research Consortium, agree that a combination of factors, beginning with the excessive build-up of the peptide Abeta42 triggering the development of tau tangles, nerve cell death, and inflammation are all required for Alzheimer’s pathology.
Posted: Sep. 5, 2012
A new study by David Holtzman of Cure Alzheimer’s Fund’s Research Consortium published by the journal “Science Translational Medicine” brings sharp new focus on the direct relationship between the accumulation of Abeta in the brain and notorious sleep problems associated with Alzheimer's disease. This NIH-funded study (also supported by Ellison Medical Foundation) was made possible by early pilot studies initiated by the Cure Alzheimer's Fund --- another great example of leveraging innovative research ideas into substantially funded, high impact projects.
Posted: Jun. 6, 2012
Alzheimer’s research for many years has been dominated by a focus on Abeta “plaques,” a focus that largely has overlooked the other infamous hallmark of the disease—the tau-based neurofibrillary “tangles.” The research world recently has broadened its scope to include significant research into tau.
© 2005-2014 Cure Alzheimer's Fund. All rights reserved.